E2 ModerateModerate confidencePEM ✗ObservationalPeer-reviewedMachine draft
Prevalence of Bodily Distress Syndrome and Prediction of Patient Outcomes: Cohort Study of 3762 Individuals With Persistent Pain.
Landmark, Live, Sunde, Hans Fredrik, Fors, Egil A et al. · European journal of pain (London, England) · 2026 · DOI
Quick Summary
This study looked at how multiple physical symptoms often occur together in people with chronic pain, using a framework called Bodily Distress Syndrome (BDS). Among 3,762 people attending a specialized pain clinic, 92.5% showed moderate to severe BDS, and those with BDS experienced more severe symptoms and psychological stress. After one year, people with BDS improved less and reported less benefit from treatment compared to those without BDS.
Why It Matters
Because ME/CFS patients commonly present with multisystem symptoms similar to BDS (fatigue, pain, cognitive dysfunction, sleep disturbance), understanding BDS prevalence and prognostic significance in pain populations may help clinicians identify complex symptom patterns earlier and tailor interdisciplinary treatment approaches. The framework's association with poorer long-term outcomes supports the need for mechanism-oriented interventions targeting the underlying drivers of symptom clusters in post-infectious and functional disorders.
Observed Findings
- 92.5% of 3,762 tertiary pain clinic patients met criteria for moderate or severe BDS
- Individuals meeting BDS criteria reported significantly more severe physical symptoms, elevated psychological distress, and reduced health-related quality of life at baseline
- Severe BDS was more prevalent among women, those without higher education, and individuals outside the workforce
- After 12 months, individuals with BDS showed less improvement in disability and reported lower perceived treatment benefit compared to non-BDS cases
- BDS severity was consistently associated with negative prognostic indicators including pain catastrophizing and perceived injustice
Inferred Conclusions
- BDS is a highly prevalent construct in tertiary pain populations that captures multisystem symptom complexity not fully described by single-syndrome diagnoses
- BDS severity predicts worse functional outcomes and lower treatment response at 12-month follow-up, supporting its prognostic utility
- Routine BDS screening in specialized pain services could identify patients with complex symptom profiles and guide mechanism-oriented, interdisciplinary treatment approaches
- Demographic disparities in BDS severity suggest potential differences in symptom expression, healthcare access, or occupational functioning related to sex, education, and employment status
What This Study Does Not Prove
This study does not establish causation—it shows that BDS severity correlates with worse outcomes but does not prove that BDS causes poor prognosis. The findings are specific to a tertiary pain clinic population and may not apply to ME/CFS populations, general practice, or mild pain populations. The study cannot determine whether BDS is a distinct disease entity or a phenotypic description of overlapping functional somatic conditions.
Tags
Symptom:Unrefreshing SleepPainFatigue
Method Flag:PEM Not DefinedNo ControlsMixed Cohort
Metadata
- DOI
- 10.1002/ejp.70212
- PMID
- 41557875
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026